Prolactin and growth hormone secretion after thyrotrophin-releasing hormone infusion and dopaminergic (DA2) blockade in infertile patients with minimal/mild endometriosis

Human Reproduction

Volumn 17, Issue 4, 2002, Pages 960-965

  Cunha Filho, J S ^a   Gross, J L ^a   Lemos, N A ^a   Dias, E C ^a   Vettori, D ^a   Souza, C A ^a   Passos, E P ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Endometriosis; GH secretion; Infertility; Prolactin secretion

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; ESTRADIOL; GLUCOSE; GROWTH HORMONE; INSULIN; METOCLOPRAMIDE; PROLACTIN; PROTIRELIN; SOMATOMEDIN C;

ANOVULATION; ARTICLE; CASE CONTROL STUDY; CHEMOLUMINESCENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINE RECEPTOR BLOCKING; DRUG INFUSION; ENDOCRINE DISEASE; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; UTERINE TUBE OCCLUSION;

EID: 0036115532     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.4.960     Document Type: Article

References (37)

1. Prolactin and its response to the luteinizing hormone-releasing hormone thyrotrophin-releasing hormone test in patients with endometriosis before, during and after treatment with danazol
2. Revised American Fertility Society classification of endometriosis
3. Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: Studies with metoclopramide
4. Prolactin response to thyrotrophin-releasing hormone in women with infertility and/or randomly elevated serum prolactin levels
5. Occult hyperprolactinemia in infertile women
6. Pituitary-ovarian dysfunction and endometriosis
7. Mild endometriosis and infertility: A critical review of epidemiologic data, diagnostic pitfalls, and classification limits
8. Metoclopramide stimulation: A test of growth hormone reserve in adolescents males
9. Hyperprolactinemia and luteal phase insufficiency in infertile patients with mild and minimal endometriosis
10. Neuroendocrine control of growth hormone secretion in humans
11. Disease of anterior pituitary
12. Follicular hormonal environment and embryo quality in women with endometriosis
13. Evaluation of serum prolactin levels in patients with endometriosis and infertility
14. Reduced preovulatory granulosa cell steroidogenesis in women with endometriosis
15. The galactorrhoea endometriosis syndrome
16. The impact of endometriosis on the reproductive outcome of infertile patients
17. Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to CRF 1-29
18. Growth hormone response to thyrotrophin-releasing hormone in women with polycystic ovarian syndrome
19. The potential relevance of growth hormone to female reproductive physiology and pathophysiology
20. Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations
21. The influence of latent hyperprolactinemia on the levels of LH, FSH, E2 and T in the midfollicular phase of the cycle
22. Effects of dopaminergic blockade on the secretion of growth hormone and prolactin in man
23. Direct gonadotrophic effect of growth hormone on oestradiol by human granulosa cells in vitro
24. PRL, TSH and their response to the TRH test in patients with endometriosis before, during, and after treatment with danazol
25. Prolactin hyperstimulation in response to thyrotrophin-releasing hormone in patients with endometriosis
26. Endometriosis-associated infertility: A critical review of therapeutic approaches
27. Endometriosis
28. Effect of growth hormone on steroidogenesis, insulin-like growth factor-I (IGF-I) and IGF binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells
29. Provocative tests of prolactin before, during and after long-term danazol treatment in patients with endometriosis
30. Transient hyperprolactinemia during cycle stimulation: Influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment
31. Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation
32. Dynamic testing in reproductive endocrinology
33. Prolactin response to thyrotrophin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy
34. Role of dopamine in the regulation of growth hormone secretion: Dopamine and bromocriptine augment growth hormone-releasing hormone stimulated GH secretion in normal man
35. Mechanisms that observe estradiol's induction of increased prolactin concentrations: Evidence of amplitude modulation of spontaneous prolactin secretory bursts
36. Danazol and prolactin status in patients with endometriosis